Moderna gets $50M investment for Ebola vaccine candidate
Corroborated by 4 sources from 4 publishers
TL;DR
Reports differ across sources; according to arstechnica.com, raging outbreak CEPI will also provide $3.2 million to the International AIDS Vaccine Initiative, which is developing a vaccine that uses the same technology as Merck’s approved Ebola vaccine, Ervebo, which targets the more common Zaire ebolavirus strain.
Sources
1
The Hill Healthcare
https://thehill.com/policy/healthcare/5904431-ebola-vaccine-moderna-cepi
2
Ars Technica
https://arstechnica.com/health/2026/06/moderna-gets-50-million-to-develop-mrna-ebola-vaccine-against-bundibugyo
3
Investing.com News
https://www.investing.com/news/stock-market-news/moderna-partners-with-global-health-coalition-to-develop-bundibugyo-ebola-vaccine-4718359
4
CNBC 38818154
https://www.cnbc.com/video/2026/06/01/moderna-ceo-stephane-bancel-on-int-trial-results-theres-duration-of-efficacy-which-is-exciting.html